CovalX and Bruker Daltonics Announce Strategic Collaboration

News   Jun 06, 2013

 
CovalX and Bruker Daltonics Announce Strategic Collaboration
 
 
 

RELATED ARTICLES

Pioneering Method Enables Screening Millions of Human Antibodies for Rapid Therapeutic Discovery

News

A paper just published in Nature Biotechnology outlines a pioneering method of screening a person's diverse set of antibodies for rapid therapeutic discovery.

READ MORE

Possible Biomarker to Identify Who Would Benefit from Immunotherapy

News

While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments. In a new study, researchers examined tissue samples from melanoma and ovarian cancer patients treated with immunotherapies and found a link between the percentage of antigen-presenting cells expressing PD-L1 and an objective clinical response to treatment.

READ MORE

Fight Against Cancer: Drug Combination Helps Kickstart the Immune System

News

Scientists from King's College London have found a way to boost the immune system to help it fight back against cancer.

The breakthrough involves the first ever use of a combination of chemotherapy and a drug being trialled as a treatment for neonatal jaundice, that together help kick start the body's natural defences.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Biopharma Cell Science Diagnostics Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE